198 related articles for article (PubMed ID: 35447103)
1. Combinatorial epigenetic mechanisms of sulforaphane, genistein and sodium butyrate in breast cancer inhibition.
Sharma M; Tollefsbol TO
Exp Cell Res; 2022 Jul; 416(1):113160. PubMed ID: 35447103
[TBL] [Abstract][Full Text] [Related]
2. The Effects of Combinatorial Genistein and Sulforaphane in Breast Tumor Inhibition: Role in Epigenetic Regulation.
Paul B; Li Y; Tollefsbol TO
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29899271
[TBL] [Abstract][Full Text] [Related]
3. A Novel Combination of Withaferin A and Sulforaphane Inhibits Epigenetic Machinery, Cellular Viability and Induces Apoptosis of Breast Cancer Cells.
Royston KJ; Udayakumar N; Lewis K; Tollefsbol TO
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534825
[TBL] [Abstract][Full Text] [Related]
4. Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms.
Royston KJ; Paul B; Nozell S; Rajbhandari R; Tollefsbol TO
Exp Cell Res; 2018 Jul; 368(1):67-74. PubMed ID: 29689276
[TBL] [Abstract][Full Text] [Related]
5. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
Abbas A; Hall JA; Patterson WL; Ho E; Hsu A; Al-Mulla F; Georgel PT
Biochem Cell Biol; 2016 Feb; 94(1):71-81. PubMed ID: 26458818
[TBL] [Abstract][Full Text] [Related]
6. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines.
Meeran SM; Patel SN; Tollefsbol TO
PLoS One; 2010 Jul; 5(7):e11457. PubMed ID: 20625516
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic reactivation of estrogen receptor-α (ERα) by genistein enhances hormonal therapy sensitivity in ERα-negative breast cancer.
Li Y; Meeran SM; Patel SN; Chen H; Hardy TM; Tollefsbol TO
Mol Cancer; 2013 Feb; 12():9. PubMed ID: 23379261
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic-based combinatorial resveratrol and pterostilbene alters DNA damage response by affecting SIRT1 and DNMT enzyme expression, including SIRT1-dependent γ-H2AX and telomerase regulation in triple-negative breast cancer.
Kala R; Shah HN; Martin SL; Tollefsbol TO
BMC Cancer; 2015 Oct; 15():672. PubMed ID: 26459286
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for the Inhibition of Colon Cancer Cells by Sulforaphane through Epigenetic Modulation of MicroRNA-21 and Human Telomerase Reverse Transcriptase (hTERT) Down-regulation.
Martin SL; Kala R; Tollefsbol TO
Curr Cancer Drug Targets; 2018; 18(1):97-106. PubMed ID: 28176652
[TBL] [Abstract][Full Text] [Related]
10. Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs.
Okonkwo A; Mitra J; Johnson GS; Li L; Dashwood WM; Hegde ML; Yue C; Dashwood RH; Rajendran P
Mol Nutr Food Res; 2018 Sep; 62(18):e1800228. PubMed ID: 29924908
[TBL] [Abstract][Full Text] [Related]
11. A novel combinatorial approach using sulforaphane- and withaferin A-rich extracts for prevention of estrogen receptor-negative breast cancer through epigenetic and gut microbial mechanisms.
Rahman MM; Wu H; Tollefsbol TO
Sci Rep; 2024 May; 14(1):12091. PubMed ID: 38802425
[TBL] [Abstract][Full Text] [Related]
12. Sulforaphane and iberin are potent epigenetic modulators of histone acetylation and methylation in malignant melanoma.
Mitsiogianni M; Trafalis DT; Franco R; Zoumpourlis V; Pappa A; Panayiotidis MI
Eur J Nutr; 2021 Feb; 60(1):147-158. PubMed ID: 32215717
[TBL] [Abstract][Full Text] [Related]
13. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications.
Meeran SM; Patel SN; Li Y; Shukla S; Tollefsbol TO
PLoS One; 2012; 7(5):e37748. PubMed ID: 22662208
[TBL] [Abstract][Full Text] [Related]
14. Genistein Induces Alterations of Epigenetic Modulatory Signatures in Human Cervical Cancer Cells.
Sundaram MK; Ansari MZ; Al Mutery A; Ashraf M; Nasab R; Rai S; Rais N; Hussain A
Anticancer Agents Med Chem; 2018; 18(3):412-421. PubMed ID: 28925878
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase activity and vitamin D-dependent gene expressions in relation to sulforaphane in human breast cancer cells.
Hossain S; Liu Z; Wood RJ
J Food Biochem; 2020 Feb; 44(2):e13114. PubMed ID: 31846091
[TBL] [Abstract][Full Text] [Related]
16. The impact of cruciferous vegetable isothiocyanates on histone acetylation and histone phosphorylation in bladder cancer.
Abbaoui B; Telu KH; Lucas CR; Thomas-Ahner JM; Schwartz SJ; Clinton SK; Freitas MA; Mortazavi A
J Proteomics; 2017 Mar; 156():94-103. PubMed ID: 28132875
[TBL] [Abstract][Full Text] [Related]
17. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
Clarke JD; Hsu A; Yu Z; Dashwood RH; Ho E
Mol Nutr Food Res; 2011 Jul; 55(7):999-1009. PubMed ID: 21374800
[TBL] [Abstract][Full Text] [Related]
19. Dietary histone deacetylase inhibitors: from cells to mice to man.
Dashwood RH; Ho E
Semin Cancer Biol; 2007 Oct; 17(5):363-9. PubMed ID: 17555985
[TBL] [Abstract][Full Text] [Related]
20. HDAC5-LSD1 axis regulates antineoplastic effect of natural HDAC inhibitor sulforaphane in human breast cancer cells.
Cao C; Wu H; Vasilatos SN; Chandran U; Qin Y; Wan Y; Oesterreich S; Davidson NE; Huang Y
Int J Cancer; 2018 Sep; 143(6):1388-1401. PubMed ID: 29633255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]